Plante Moran Financial Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Plante Moran Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$150.52 - $190.14 $4,666 - $5,894	-31 Reduced 79.49%	8 $1,000
Q4 2024 Feb 05, 2025	BUY	$178.58 - $220.69 $5,535 - $6,841	31 Added 387.5%	39 $7,000
Q3 2022 Nov 02, 2022	SELL	$182.44 - $250.54 $1,459 - $2,004	-8 Reduced 50.0%	8 $2,000
Q2 2022 Aug 02, 2022	BUY	$204.13 - $302.4 $1,633 - $2,419	8 Added 100.0%	16 $3,000
Q1 2022 May 06, 2022	SELL	$255.51 - $362.11 $2,044 - $2,896	-8 Reduced 50.0%	8 $2,000

Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $2,353 - $2,973	8 Added 100.0%	16 $6,000
Q4 2020 Feb 09, 2021	BUY	$222.0 - $252.62 $1,776 - $2,020	8 New	8 $2,000

652

51.7M

194K

174K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.